Magnera Reports $3.3 Billion in Fiscal 2026 Sales, Adjusted EBITDA Rises 7% to $378 Million

The company records fourth-quarter Adjusted EBITDA of $97 million, generates $115 million in free cash flow for the year and repays $122 million of debt.
Magnera has reported net sales of $3.3 billion and Adjusted EBITDA of $378 million for fiscal year 2026, compared with $3.204 billion and $354 million, respectively, in the previous fiscal year. For the fourth quarter ended September 2026, the company recorded net sales of $851 million and Adjusted EBITDA of $97 million, supported by favourable price-cost spreads and ongoing cost optimisation initiatives.
Magnera Reports Fourth-Quarter and Full-Year Financial Performance
For the fourth quarter of fiscal 2026, Magnera reported the following financial results:
- Net sales: $851 million, compared with $839 million in the corresponding period of 2025.
- Operating loss: $90 million, including $106 million in goodwill and other impairment charges.
- Adjusted EBITDA: $97 million, an 8% increase compared with $90 million in the previous year.
- Cash from operations: $99 million.
- Debt repayments: $57 million.
For the full fiscal year 2026, the company reported:
- Net sales: $3.3 billion, compared with $3.204 billion in fiscal 2025.
- Operating loss: $37 million, including $106 million in goodwill and other impairment charges.
- Adjusted EBITDA: $378 million, compared with $354 million in the previous year.
- Free cash flow: $115 million, representing a yield of over 25% as of year-end.
- Debt repayments: $122 million.
CEO Highlights Cost Optimisation and Operational Performance
Curt Begle, CEO of Magnera, said:
“We finished Fiscal 2026 with an impressive 8% Adjusted EBITDA improvement in the fourth quarter compared to last year and delivered strong overall results for the full year surpassing prior year by nearly 4%. Through the successful implementation of Project CORE, ongoing realization of synergies, and a relentless focus on operational excellence, we are optimizing our cost structure, enhancing profitability, and generating exceptional cash flow. Our teams delivered these results while navigating inflationary pressures and dynamic demand conditions across our end markets, demonstrating the resilience and flexibility of our operating model.
“As we enter fiscal 2027, we remain focused on driving profitable growth and advancing our productivity and cost initiatives. While we remain mindful of the broader macroeconomic environment, we are confident that the strength of our team, our market positions, and our disciplined execution will continue to support sustainable earnings growth and strong cash generation.”
Fourth-Quarter Financial Performance Across Business Segments
Consolidated performance
Magnera's fourth-quarter net sales increased to $851 million from $839 million in the corresponding period of the previous year.
The increase included a $43 million rise in selling prices, primarily reflecting the pass-through of higher raw material costs. This was partly offset by a 4% decline in organic volumes.
Lower volumes were primarily associated with softer healthcare demand in the Americas and continued general market weakness in Europe.
Adjusted EBITDA increased by 8%, supported mainly by a favourable price-cost spread of $9 million.
Americas
In the Americas segment, higher selling prices contributed $19 million to the increase in net sales, primarily reflecting the pass-through of increased raw material costs. This was partially offset by a 2% decline in organic volumes.
Adjusted EBITDA improved mainly due to a favourable price-cost spread of $4 million, supported by benefits from Project CORE and merger synergies.
Rest of World
Net sales in the Rest of World segment remained essentially flat. A $24 million increase in selling prices, resulting from the pass-through of higher raw material costs, was offset by a 6% decline in organic volumes.
The segment's Adjusted EBITDA improvement was primarily driven by a favourable price-cost spread of $5 million, reflecting benefits from Project CORE and synergies. These gains were partly offset by the impact of lower volumes.
Free Cash Flow Reaches $115 Million in Fiscal 2026
Magnera continued its focus on strengthening credit metrics through debt reduction.
The company's fiscal 2026 cash flow figures included:
Financial metric | Fiscal 2026 |
|---|---|
Cash flow from operating activities | $178 million |
Additions to property, plant and equipment, net | $63 million |
Free cash flow | $115 million |
Free cash flow yield | Over 25% |
The free cash flow yield is calculated using the company's market capitalisation as of the close of business in September 2026.
During fiscal 2026, Magnera repaid $122 million of debt, while its fourth-quarter debt repayments amounted to $57 million.
Magnera Provides Fiscal 2027 Financial Guidance
For fiscal year 2027, Magnera has provided the following financial outlook:
- Adjusted EBITDA: $390 million to $410 million.
- Free cash flow: $110 million to $130 million.
- Cash flow from operations: $195 million to $215 million.
The company stated that its priorities for the coming fiscal year include profitable growth, productivity improvements and continued cost initiatives.
Investor Conference Call Scheduled for November 19
Magnera will host an investor conference call on November 19, 2026, at 10:00 AM U.S. Eastern Time to discuss its fourth-quarter and full-year fiscal 2026 results.